SCHEMBL30587155

SCHEMBL30587155

O=C(Nc1ccc(-c2nnc(-c3ccccc3)o2)cc1)c1ccnnc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.61
RAB9A P51151 7/20 0.61
ALDH1A1 P00352 6/20 0.61
SMN1; SMN2 Q16637 4/20 0.61
TSHR P16473 3/20 0.61
HPGD P15428 3/20 0.61
SMO Q99835 1/20 0.58
HSD17B10 Q99714 4/20 0.57
MAPK1 P28482 2/20 0.57
USP2 O75604 2/20 0.57
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
POLB P06746 2/20 0.55
TP53 P04637 1/20 0.55
ABCG2 Q9UNQ0 1/20 0.54
HDAC6 Q9UBN7 1/20 0.53
LMNA P02545 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24473983 1.00 NPC1 (0.61) NPC1RAB9AALDH1A1SMN1; SMN2TSHR
SCHEMBL24474001 0.85 SMN1; SMN2 (0.67) NPC1RAB9AALDH1A1SMN1; SMN2TSHR
SCHEMBL8770855 0.83 NPC1 (0.74) NPC1RAB9AALDH1A1SMN1; SMN2TSHR
SCHEMBL30587153 0.79 TSHR (0.64) NPC1RAB9AALDH1A1SMN1; SMN2TSHR
SCHEMBL24473977 0.79 TSHR (0.64) NPC1RAB9AALDH1A1SMN1; SMN2TSHR
SCHEMBL26078553 0.79 ALDH1A1 (0.64) NPC1RAB9AALDH1A1SMN1; SMN2TSHR
SCHEMBL24473971 0.79 ADCY1 (0.74) NPC1RAB9AALDH1A1SMN1; SMN2TSHR
SCHEMBL26078532 0.79 NPC1 (0.64) NPC1RAB9AALDH1A1SMN1; SMN2TSHR
SCHEMBL24474019 0.79 KDM4E (0.74) NPC1RAB9AALDH1A1SMN1; SMN2TSHR
SCHEMBL30587159 0.78 SMO (0.63) NPC1RAB9AALDH1A1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116457353-A N-substituted 4- (5-phenyl-1, 3, 4-oxadiazol-2-yl) anilines for the treatment and prophylaxis of hepatitis b virus infections 豪夫迈·罗氏有限公司 2023-07-18 CN disclosed